This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: National Institute of Health and Medical Research. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Eloise Hudry: Innovator in Alzheimer's Disease Treatment
Introduction
Eloise Hudry is a prominent inventor based in Paris, France. She has made significant contributions to the field of medical research, particularly in the treatment of Alzheimer's disease. Her innovative work has led to the development of a unique viral vector aimed at addressing this debilitating condition.
Latest Patents
Eloise Hudry holds a patent for the CYP46A1 gene, which is pivotal in the treatment of Alzheimer's disease. The invention involves a viral vector that comprises a cholesterol 24-hydroxylase (CYP46A1) encoding nucleic acid. In a preferred embodiment, the viral vector may be an Adeno-Associated Virus (AAV) vector, specifically an AAV5 vector. This vector is designed to be useful for the manufacture of a pharmaceutical composition for treating Alzheimer's disease in subjects. The administration methods include direct injection into the brain or through intravenous or intrathecal injection.
Career Highlights
Eloise Hudry is affiliated with the National Institute of Health and Medical Research, where she continues her groundbreaking work. Her research focuses on innovative solutions for complex neurological disorders, showcasing her dedication to improving patient outcomes.
Collaborations
Eloise collaborates with esteemed colleagues such as Patrick Aubourg and Nathalie Cartier-Lacave. These partnerships enhance her research efforts and contribute to the advancement of medical science.
Conclusion
Eloise Hudry's contributions to the field of Alzheimer's disease treatment through her innovative patent demonstrate her commitment to medical research and patient care. Her work is a testament to the potential of scientific innovation in addressing critical health challenges.